WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19
- PMID: 34871050
- DOI: 10.7326/J21-0009
WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19
Abstract
Rochwerg B, Agarwal A, Siemieniuk RA, et al. Update to living WHO guideline on drugs for covid-19. BMJ. 2021;374:n2219. 34556469.
Comment on
-
Update to living WHO guideline on drugs for covid-19.BMJ. 2021 Sep 23;374:n2219. doi: 10.1136/bmj.n2219. BMJ. 2021. PMID: 34556469 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical